RepRisk, the leading provider of dynamic business intelligence on environmental, social, and governance (ESG) risks, is pleased to announce the release of its first Sector Benchmarking Report focusing on the Pharmaceuticals and Biotechnology sector.
The report highlights the ESG Issues, Topic Tags, and countries mostly related to the Pharmaceuticals and Biotechnology sector, and ranks the top ten companies in the sector by the RepRisk Rating, a proprietary risk metric developed by RepRisk that facilitates corporate benchmarking and ESG integration.
The RepRisk Rating is the cornerstone of the RepRisk Director’s Brief, a corporate benchmarking report that assesses a company’s exposure to ESG risks, and benchmarks it with a customizable peer list. A customized Director’s Brief can be ordered directly from the RepRisk website as of November 9, 2016.
This Benchmarking Report is the first in a new RepRisk Publications series. The next report will benchmark companies in the Retail sector and will be published in November 2016.
To read the report, visit our website here.
RepRisk is a leading business intelligence provider, specializing in environmental, social, and governance (ESG) risk analytics and metrics.
Harnessing a proprietary, systematic framework that leverages cutting-edge technology and hands-on human intelligence in 15 languages, RepRisk curates and delivers dynamic risk information for an unlimited universe of companies.
Since 2006, RepRisk has built and continues to grow the world’s most comprehensive ESG risk database, which serves as a due diligence, research, and monitoring tool in risk management, compliance, investment management, corporate benchmarking, and supplier risk. The RepRisk ESG Risk Platform currently includes risk profiles for over 76,000 listed and non-listed companies, 19,000 projects, as well as for every sector and country in the world.
Headquartered in Zurich, Switzerland, RepRisk serves clients worldwide including global banks, insurance providers, investment managers, and corporates, helping them to manage ESG and reputational risks in day-to-day business.
RepRisk provides the transparency needed to enable better, more informed decisions.
View source version on businesswire.com: http://www.businesswire.com/news/home/20161025006416/en/Business Wire
Last updated on: 26/10/2016
PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.